Compare $CAPR vs $SPRY | Chartloom

Compare

$CAPR vs $SPRY

Capricor Therapeutics Inc · ARS Pharmaceuticals Inc

CAPR

Capricor Therapeutics Inc

SPRY

ARS Pharmaceuticals Inc

Compare $CAPR vs $SPRY

Comparing Capricor Therapeutics Inc and ARS Pharmaceuticals Inc

CAPRCapricor Therapeutics Inc

SPRYARS Pharmaceuticals Inc

CAPRCapricor Therapeutics Inc

Market cap

$453M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.84x

Rev growth (TTM)

-100.0%

YTD performance

-72.3%

52W performance

4.4%

FCF yield

-28.6%

SPRYARS Pharmaceuticals Inc

Market cap

$420M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.81x

Rev growth (TTM)

4.1%

YTD performance

-63.2%

52W performance

-61.9%

FCF yield

-46.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAPR

SPRY

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

SPRY

ARS Pharmaceuticals Inc

Market Cap

CAPR$453M

SPRY$420M

Enterprise Value

CAPR$433M

SPRY$509M

Price

CAPR$7.83

SPRY$4.23

P/E Ratio

CAPRN/A

SPRYN/A

P/S Ratio

CAPR23.36x

SPRY3.59x

EV/Sales

CAPR22.42x

SPRY4.35x

EV/EBITDA

CAPR1,019.20x

SPRY0.00x

P/B Ratio

CAPR2.11x

SPRY32.35x

P/FCF Ratio

CAPRN/A

SPRYN/A

EV/FCF

CAPR-3.33x

SPRY-2.59x

PEG Ratio

CAPRN/A

SPRYN/A

Forward P/E (NTM)

CAPRN/A

SPRYN/A

Forward P/S (NTM)

CAPR6.84x

SPRY2.81x

Revenue (TTM)

CAPR$0

SPRY$117M

Revenue Growth (YoY)

CAPR-100.0%

SPRY4.1%

Forward Rev Growth

CAPR-27.8%

SPRY46.9%

Gross Margin (TTM)

CAPR0.0%

SPRY71.4%

Operating Margin (TTM)

CAPR0.0%

SPRY0.0%

EBITDA Margin (TTM)

CAPR0.0%

SPRY-183.6%

Net Margin (TTM)

CAPR0.0%

SPRY-184.2%

FCF Margin (TTM)

CAPRN/A

SPRY-168.1%

Net Income (TTM)

CAPR$-129M

SPRY$-215M

FCF (TTM)

CAPR$-130M

SPRY$-197M

EPS (TTM)

CAPR-$2.23

SPRY-$2.17

ROE (TTM)

CAPR-5660.0%

SPRY-25667.0%

ROA (TTM)

CAPR-4397.0%

SPRY-6963.0%

ROIC (TTM)

CAPR-5562.0%

SPRY-11943.0%

Cash

CAPR$21M

SPRY$8M

Debt

CAPR$0

SPRY$97M

Net Cash/Debt

CAPR$21M

SPRY$-89M

Current Ratio (TTM)

CAPR7.35x

SPRY3.48x

Quick Ratio (TTM)

CAPR7.22x

SPRY3.13x

Debt/Equity (TTM)

CAPR0.02x

SPRY7.73x

Debt/Assets (TTM)

CAPR0.0%

SPRY0.0%

Interest Coverage (TTM)

CAPRN/A

SPRYN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

SPRY0.00x

Beta

CAPR0.59

SPRY0.92

52W Performance

CAPR4.4%

SPRY-61.9%

YTD Performance

CAPR-72.3%

SPRY-63.2%

% from 52W High

CAPR-80.6%

SPRY-67.8%

% from 52W Low

CAPR164.5%

SPRY6.1%

Asset Turnover (TTM)

CAPR0.25x

SPRY0.38x

FCF Yield (TTM)

CAPR-28.6%

SPRY-46.8%

Earnings Yield (TTM)

CAPR-28.5%

SPRY-51.3%

Dividend Yield (TTM)

CAPRN/A

SPRYN/A

Rule of 40

CAPR-100.0

SPRY-164.1

EV/GP/RG

CAPRN/A

SPRY0.16

Ticker research

View CAPR research View SPRY research

Metric	CAPR Capricor Therapeutics Inc	SPRY ARS Pharmaceuticals Inc
Market & Valuation
Market Cap	$453M	$420M
Enterprise Value	$433M	$509M
Price	$7.83	$4.23
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	3.59x
EV/Sales	22.42x	4.35x
EV/EBITDA	1,019.20x	0.00x
P/B Ratio	2.11x	32.35x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-2.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	2.81x
Revenue & Growth
Revenue (TTM)	$0	$117M
Revenue Growth (YoY)	-100.0%	4.1%
Forward Rev Growth	-27.8%	46.9%
Profitability
Gross Margin (TTM)	0.0%	71.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-183.6%
Net Margin (TTM)	0.0%	-184.2%
FCF Margin (TTM)	N/A	-168.1%
Net Income (TTM)	$-129M	$-215M
FCF (TTM)	$-130M	$-197M
EPS (TTM)	-$2.23	-$2.17
ROE (TTM)	-5660.0%	-25667.0%
ROA (TTM)	-4397.0%	-6963.0%
ROIC (TTM)	-5562.0%	-11943.0%
Financial Health
Cash	$21M	$8M
Debt	$0	$97M
Net Cash/Debt	$21M	$-89M
Current Ratio (TTM)	7.35x	3.48x
Quick Ratio (TTM)	7.22x	3.13x
Debt/Equity (TTM)	0.02x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.92
52W Performance	4.4%	-61.9%
YTD Performance	-72.3%	-63.2%
% from 52W High	-80.6%	-67.8%
% from 52W Low	164.5%	6.1%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.38x
FCF Yield (TTM)	-28.6%	-46.8%
Earnings Yield (TTM)	-28.5%	-51.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-164.1
EV/GP/RG	N/A	0.16
Ticker research	View CAPR research	View SPRY research

Valuation

P/S Ratio

SPRY

3.59x

CAPR

23.36x

EV/FCF

CAPR

-3.33x

SPRY

-2.59x

Growth & revenue

Revenue Growth TTM

SPRY

4.1%

CAPR

-100.0%

Forward Revenue Growth

SPRY

46.9%

CAPR

-27.8%

Profitability & performance

Gross Margin

SPRY

71.4%

CAPR

0.0%

ROE

CAPR

-5660.0%

SPRY

-25667.0%

FCF Yield %

CAPR

-28.6%

SPRY

-46.8%

52-Week Performance

CAPR

4.4%

SPRY

-61.9%

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

SPRY

ARS Pharmaceuticals Inc

Market Cap

CAPR$453M

SPRY$420M

Enterprise Value

CAPR$433M

SPRY$509M

Price

CAPR$7.83

SPRY$4.23

P/E Ratio

CAPRN/A

SPRYN/A

P/S Ratio

CAPR23.36x

SPRY3.59x

EV/Sales

CAPR22.42x

SPRY4.35x

EV/EBITDA

CAPR1,019.20x

SPRY0.00x

P/B Ratio

CAPR2.11x

SPRY32.35x

P/FCF Ratio

CAPRN/A

SPRYN/A

EV/FCF

CAPR-3.33x

SPRY-2.59x

PEG Ratio

CAPRN/A

SPRYN/A

Forward P/E (NTM)

CAPRN/A

SPRYN/A

Forward P/S (NTM)

CAPR6.84x

SPRY2.81x

Revenue (TTM)

CAPR$0

SPRY$117M

Revenue Growth (YoY)

CAPR-100.0%

SPRY4.1%

Forward Rev Growth

CAPR-27.8%

SPRY46.9%

Gross Margin (TTM)

CAPR0.0%

SPRY71.4%

Operating Margin (TTM)

CAPR0.0%

SPRY0.0%

EBITDA Margin (TTM)

CAPR0.0%

SPRY-183.6%

Net Margin (TTM)

CAPR0.0%

SPRY-184.2%

FCF Margin (TTM)

CAPRN/A

SPRY-168.1%

Net Income (TTM)

CAPR$-129M

SPRY$-215M

FCF (TTM)

CAPR$-130M

SPRY$-197M

EPS (TTM)

CAPR-$2.23

SPRY-$2.17

ROE (TTM)

CAPR-5660.0%

SPRY-25667.0%

ROA (TTM)

CAPR-4397.0%

SPRY-6963.0%

ROIC (TTM)

CAPR-5562.0%

SPRY-11943.0%

Cash

CAPR$21M

SPRY$8M

Debt

CAPR$0

SPRY$97M

Net Cash/Debt

CAPR$21M

SPRY$-89M

Current Ratio (TTM)

CAPR7.35x

SPRY3.48x

Quick Ratio (TTM)

CAPR7.22x

SPRY3.13x

Debt/Equity (TTM)

CAPR0.02x

SPRY7.73x

Debt/Assets (TTM)

CAPR0.0%

SPRY0.0%

Interest Coverage (TTM)

CAPRN/A

SPRYN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

SPRY0.00x

Beta

CAPR0.59

SPRY0.92

52W Performance

CAPR4.4%

SPRY-61.9%

YTD Performance

CAPR-72.3%

SPRY-63.2%

% from 52W High

CAPR-80.6%

SPRY-67.8%

% from 52W Low

CAPR164.5%

SPRY6.1%

Asset Turnover (TTM)

CAPR0.25x

SPRY0.38x

FCF Yield (TTM)

CAPR-28.6%

SPRY-46.8%

Earnings Yield (TTM)

CAPR-28.5%

SPRY-51.3%

Dividend Yield (TTM)

CAPRN/A

SPRYN/A

Rule of 40

CAPR-100.0

SPRY-164.1

EV/GP/RG

CAPRN/A

SPRY0.16

Ticker research

View CAPR research View SPRY research

Metric	CAPR Capricor Therapeutics Inc	SPRY ARS Pharmaceuticals Inc
Market & Valuation
Market Cap	$453M	$420M
Enterprise Value	$433M	$509M
Price	$7.83	$4.23
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	3.59x
EV/Sales	22.42x	4.35x
EV/EBITDA	1,019.20x	0.00x
P/B Ratio	2.11x	32.35x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-2.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	2.81x
Revenue & Growth
Revenue (TTM)	$0	$117M
Revenue Growth (YoY)	-100.0%	4.1%
Forward Rev Growth	-27.8%	46.9%
Profitability
Gross Margin (TTM)	0.0%	71.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-183.6%
Net Margin (TTM)	0.0%	-184.2%
FCF Margin (TTM)	N/A	-168.1%
Net Income (TTM)	$-129M	$-215M
FCF (TTM)	$-130M	$-197M
EPS (TTM)	-$2.23	-$2.17
ROE (TTM)	-5660.0%	-25667.0%
ROA (TTM)	-4397.0%	-6963.0%
ROIC (TTM)	-5562.0%	-11943.0%
Financial Health
Cash	$21M	$8M
Debt	$0	$97M
Net Cash/Debt	$21M	$-89M
Current Ratio (TTM)	7.35x	3.48x
Quick Ratio (TTM)	7.22x	3.13x
Debt/Equity (TTM)	0.02x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.92
52W Performance	4.4%	-61.9%
YTD Performance	-72.3%	-63.2%
% from 52W High	-80.6%	-67.8%
% from 52W Low	164.5%	6.1%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.38x
FCF Yield (TTM)	-28.6%	-46.8%
Earnings Yield (TTM)	-28.5%	-51.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-164.1
EV/GP/RG	N/A	0.16
Ticker research	View CAPR research	View SPRY research